Why Pharmaceutical Companies Are Accelerating Investments in...

bir ses eklendi Other

2026-06-15 14:11:01 -

Why Pharmaceutical Companies Are Accelerating Investments in Autoimmune Biosimilars

Autoimmune Biosimilar Drug Market According to the latest report published by Data Bridge Market Research, the Autoimmune Biosimilar Drug Market The global autoimmune biosimilar drug market size was valued at USD 415.80 million in 2025 and is expected to reach USD 879.70 million by 2033, at a CAGR of 9.80% during the forecast period Autoimmune...

0 Yorumlar 0 hisse senetleri 74 Views 0 önizleme